Clinical Trial

Allergy Delabeling in Antibiotic Stewardship - Evaluations

Study acronym: RENEW-EVAL
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this RENEW-EVAL project is to understand the potential barriers to implementation of the RENEW intervention into the routine clinical care of patients with a hematological malignancy.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-05-02; most recent amendment 2026-06-04.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-12-09
Trial Details
NCT Number NCT06967467
Lead Sponsor Abramson Cancer Center at Penn Medicine
Collaborators: University of Utah
Conditions Beta Lactam Allergy in Patients With a Hematologic Malignancy
Enrollment 80 participants
Start Date 2025-12-01
Primary Completion 2028-09 (estimated)
Study Completion 2029-10 (estimated)
Updated on ClinicalTrials.gov 2026-06-05